214 related articles for article (PubMed ID: 1847495)
1. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.
Rothman RB; Reid A; Mahboubi A; Kim CH; De Costa BR; Jacobson AE; Rice KC
Mol Pharmacol; 1991 Feb; 39(2):222-32. PubMed ID: 1847495
[TBL] [Abstract][Full Text] [Related]
2. Computer-assisted modeling of multiple dextromethorphan and sigma binding sites in guinea pig brain.
Zhou GZ; Musacchio JM
Eur J Pharmacol; 1991 Apr; 206(4):261-9. PubMed ID: 1655487
[TBL] [Abstract][Full Text] [Related]
3. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain.
Hellewell SB; Bowen WD
Brain Res; 1990 Sep; 527(2):244-53. PubMed ID: 2174717
[TBL] [Abstract][Full Text] [Related]
4. 1,3-Di(2-[5-3H]tolyl)guanidine labels more than one site in rat forebrain.
Codd EE; Shank RP
Eur J Pharmacol; 1992 Jul; 217(2-3):149-52. PubMed ID: 1425936
[TBL] [Abstract][Full Text] [Related]
5. Competitive interactions at [3H]1,3-di(2-tolyl)guanidine (DTG)-defined sigma recognition sites in guinea pig brain.
DeHaven-Hudkins DL; Fleissner LC
Life Sci; 1992; 50(9):PL65-70. PubMed ID: 1346920
[TBL] [Abstract][Full Text] [Related]
6. Receptor binding profiles of KB-5492, a novel anti-ulcer agent, at sigma receptors in guinea-pig brain.
Harada Y; Hara H; Sukamoto T
Eur J Pharmacol; 1994 May; 256(3):321-8. PubMed ID: 8045277
[TBL] [Abstract][Full Text] [Related]
7. Characterization of specific binding sites for [3H]-1,3-di-o-tolyl-guanidine (DTG) in the rat glioma cell line C6-BU-1.
Georg A; Friedl A
Glia; 1992; 6(4):258-63. PubMed ID: 1464457
[TBL] [Abstract][Full Text] [Related]
8. Characterization of specific (+)-[3H]N-allylnormetazocine and [3H]1,3-di(2-tolyl)guanidine binding sites in porcine gastric fundic mucosa.
Harada Y; Hara H; Sukamoto T
J Pharmacol Exp Ther; 1994 Jun; 269(3):905-10. PubMed ID: 8014877
[TBL] [Abstract][Full Text] [Related]
9. [3H]1,3-Di(2-tolyl)guanidine labels two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel blockers and sigma ligands.
Rothman RB; Mahboubi A; Reid AA; Kim CH; deCosta BR; Jacobson AE; Rice KC
NIDA Res Monogr; 1990; 105():335-6. PubMed ID: 1652074
[No Abstract] [Full Text] [Related]
10. 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs.
Weber E; Sonders M; Quarum M; McLean S; Pou S; Keana JF
Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8784-8. PubMed ID: 2877462
[TBL] [Abstract][Full Text] [Related]
11. Interaction of 1,3-di(2-[5-3H]tolyl) guanidine with sigma 2 binding sites in rat heart membrane preparations.
Dumont M; Lemaire S
Eur J Pharmacol; 1991 Dec; 209(3):245-8. PubMed ID: 1665796
[TBL] [Abstract][Full Text] [Related]
12. Multiple [3H]DTG binding sites in guinea pig cerebellum: evidence for the presence of non-specific binding.
Basile AS; DeCosta B; Paul IA
Eur J Pharmacol; 1994 Feb; 252(2):139-46. PubMed ID: 8157054
[TBL] [Abstract][Full Text] [Related]
13. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
[TBL] [Abstract][Full Text] [Related]
14. Binding of sigma-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes.
Itzhak Y; Stein I; Zhang SH; Kassim CO; Cristante D
J Pharmacol Exp Ther; 1991 Apr; 257(1):141-8. PubMed ID: 1850463
[TBL] [Abstract][Full Text] [Related]
15. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain.
Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y
Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488
[TBL] [Abstract][Full Text] [Related]
16. Characterization of binding sites for [3H]-DTG, a selective sigma receptor ligand, in the sheep pineal gland.
Abreu P; Sugden D
Biochem Biophys Res Commun; 1990 Sep; 171(2):875-81. PubMed ID: 2169739
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of two sigma-like binding sites in the mouse neuroblastoma x rat glioma hybrid cell line NG108-15.
Georg A; Friedl A
J Pharmacol Exp Ther; 1991 Nov; 259(2):479-83. PubMed ID: 1658298
[TBL] [Abstract][Full Text] [Related]
18. Discrepancies in characterization of sigma sites in the mouse central nervous system.
Kovács KJ; Larson AA
Eur J Pharmacol; 1995 Oct; 285(2):127-34. PubMed ID: 8566130
[TBL] [Abstract][Full Text] [Related]
19. Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes.
Nguyen VH; Kassiou M; Johnston GA; Christie MJ
Eur J Pharmacol; 1996 Sep; 311(2-3):233-40. PubMed ID: 8891604
[TBL] [Abstract][Full Text] [Related]
20. [3H]1,3-di(2-tolyl) guanidine binds to a sigma 2 receptor on Jurkat cell membranes, but sigma compounds fail to influence immunomodulatory events in human peripheral blood lymphocytes.
DeHaven-Hudkins DL; Daubert JD; Sawutz DG; Tiberio L; Baine Y
Immunopharmacology; 1996 Oct; 35(1):27-39. PubMed ID: 8913792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
